Gold University of Minnesota M. Skip to main content.University of Minnesota.
Driven to Discover.
Molecular and Cellular Therapy
What's Inside

MCT Home


  Home > About the MCT > John E. Wagner, M.D., Scientific Director

John E. Wagner, M.D., Scientific Director

John E. Wagner, M.D. is a Professor of Pediatrics and Division Director of the Hematology-Oncology and Blood and Marrow Transplantation Program.  He is Scientific Director of Clinical Research of the Stem Cell Institute at the University of Minnesota Medical School. In addition, Dr. Wagner is the Scientific Director of Molecular and Cellular Therapeutics and the Clinical Trials Office of the NCI designated Cancer Center at the University of Minnesota. He currently holds three endowed chairs – Variety Club Chair in Molecular and Cellular Therapeutics, he is the first recipient of the Children’s Cancer Research Fund Hageboeck Chair in Pediatric Oncology and most recently was awarded the University of Minnesota McKnight Presidential Chair in Hematology and Oncology.  Previously, he held the Albert and Eva Corniea Chair of Clinical Research; he was also the first recipient of this Chair.  He is an experienced clinical investigator and internationally recognized as an expert in the field of marrow transplantation. He has 16 years of experience leading phase I/II studies specifically in the area of marrow graft engineering using physical and immunological methods and umbilical cord blood hematopoietic stem cells.

Dr. Wagner's research is focused on the development of novel strategies for preventing the immunologic complications of allogeneic hematopoietic stem cell transplantation, namely through bone marrow graft engineering and the use of neonatal umbilical cord blood. In collaboration with Catherine Verfaillie, M.D., his investigations also include ex vivo expansion of umbilical cord blood stem cells and multipotent adult progenitor cells (MAPC) as well as gene transfer studies in patients with Fanconi anemia. He has also pioneered use of embryo selection to "create" a perfectly matched donor. Dr. Wagner has authored more than 180 articles and book chapters on the subject of hematopoietic stem cell transplantation, is a member of numerous professional societies and was elected into the American Society of Clinical Investigation in 2000 and Association of Physicians in 2006. He co-chairs the Committee on Alternative Stem Cell Sources of the International Bone Marrow Transplant Registry and serves on the Board of Directors of the National Marrow Donor Program since January 2002.  Dr. Wagner is also a member of the Institute of Medicine Committee on “Establishing a National Cord Blood Stem Cell Banking Program”. 

Educational Background

  • B.A., Biological Science & Psychology, University of Delaware, Newark, Delaware, 1973 - 1977
  • M.D., Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, 1977 - 1981
  • Fellowship in Oncology, St. Christopher's Society, Philadelphia, Pennsylvania, 1978
  • Intern, Pediatrics, Duke University Medical Center, Durham, North Carolina, 1981 - 1982
  • Resident, Pediatrics, Duke University Medical Center, Durham, North Carolina, 1982 - 1984
  • Postdoctoral Fellow, Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 1984 - 1987
  • Postdoctoral Fellow, Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 1984 - 1987

Professional Background

  • Instructor, The Johns Hopkins University School of Medicine, Oncology, 1987 - 1988
  • Instructor, The Johns Hopkins University School of Medicine, Pediatrics, 1988
  • Assistant Professor, The Johns Hopkins University School of Medicine, Oncology & Pediatrics, 1988 - 1991
  • Assistant Professor, University of Minnesota Medical School, Pediatrics, 1991 - 1993
  • Attending Physician, University of Minnesota Medical School, Pediatric Bone Marrow Transplant Unit, 1991 - present
  • Associate Professor, University of Minnesota Medical School, Pediatrics, 1994 - 1999
  • Member, University of Minnesota Cancer Center, 1994 - present
  • Associate Director, University of Minnesota Medical School, Pediatric Bone Marrow Transplantation, 1995 - 2005
  • Director, Fairview-University Medical Center, Bone Marrow Transplant New Program, 1997 - present
  • Professor of Pediatrics, University of Minnesota Medical School, Pediatrics, 1999 - present
  • Associate Member, University of Minnesota, Division of Epidemiology, School of Public Health, 2000 - present
  • Scientific Director of Clinical Research, University of Minnesota, Blood & Marrow Transplantation and Stem Cell Institute, 2000 – present
  • Director, Division of Pediatric Hematology/Oncology and Blood & Marrow Transplantation, 2005 - present

Professional Honors

  • National Honor Society, Professional Honors, 1973
  • Cum Laude, University of Delaware, 1977
  • Outstanding College Graduate, Jefferson Medical College, 1981
  • Dean Marie Baines Award for Excellence in Pediatrics, Jefferson Medical College, 1981
  • Magna Cum Laude, Jefferson Medical College, 1981
  • Recipient, American Cancer Society Post-Doctoral Training Award , American Cancer Society, 1984
  • Higgins Scholar in Oncology Research, Hodson Trust, 1989 - 1991
  • Presidential Symposium, International Society of Experimental Hematology-Parm, 1991
  • Jundt Research Award, 1993
  • Plenary Symposium, American Society of Hematology, 1993  
  • Presidential Symposium, European Bone Marrow Transplantation-Harrogate, United Kingdom, 1994
  • Year in Hematology Session , The Clinical Research Meeting-Baltimore, Maryland, 1994
  • Plenary Symposium, International Society of Experimental Hematology-D, 1995
  • Plenary Symposium, International Society of Experimental Hematology-N, 1996
  • Plenary Symposium, American Society of Histocompatibility and Immunol, 1997  
  • Election, American Society of Clinical Investigation, 2000
  • Recognition for Excellence, Academic Health Center, University of Minnesota, 2002
  • Genetics Policy Institute Plenary Symposium on Application of Stem Cells, United Nations, 2004
  • Testimony, United States Senate, Support for Stem Cell Act, 2005
  • Election, Association of American Physicians, 2006

Professional Memberships

  • Alpha Omega Alpha, 1980 - present
  • American Medical Association, 1981 - 1983
  • Fellow American Academy of Pediatrics, 1982 - 1984
  • American Society of Pediatric Hematology/Oncology, 1988 - 1995
  • American Society of Hematology, 1989 - present
  • International Society of Experimental Hematology, 1989 - present
  • Northwestern Pediatric Society, 1992 - 1993
  • International Society of Hematotherapy and Graft Engineering, 1992 - 2001
  • American Society of Blood and Marrow Transplantation, 1993 - present
  • American Society of Clinical Investigation, 2000 – present
  • Minnesota Medical Association, 2005 – present
  • International Society of Stem Cell Research 2005 - present
  • Association of American Physicians, 2006 - present
  • National Academies Human Embryonic Stem Cell Research Advisory Committee, 2006 – present
  • America Society of Pediatric Hematolgy/Oncology 2007

Community and University Service

  • Committee on Clinical Investigation in Human Subjects, 1993-current
  • University of Minnesota Co-Team Leader, Stem Cell Biology Program, Medical School Research Priority Programs, 2001
  • Dean’s Research Advisory Panel , 2002
  • Stem Cell Institute Ethics Advisory Board (ex-officio), 2001-current
  • Medical School Clinical Research Committee, 2002  (David Cornfield, Chair)
  • Translational Research Advisory Group,  2002-current  (Mark Paller, Chair)


Patent number: 93063

Citation: U.S. Patent Application filed November 16, 1992. University Docket No. 93063 [Pluripotential Quiescent Stem Cell Population]

Publications (Selected from 148 Publications)

Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD.  Unrelated Donor Bone Marrow Transplantation for the Treatment of Fanconi Anemia.  Blood.  109:2256-62 (2007). 

Brunstein CG, Baker KS, Wagner JE.  Umbilical Cord Blood Transplantation for Myeloid Malignancies.  Current Opinion in Hematology.  14:162-9 (2007). 

Brunstein CG, Setubal DC, Wagner JE.  Expanding the Role of Umbilical Cord Blood Transplantation.  Br J Haematol. 137:20-35 (2007).

McKenna DH Jr, Sumstad D, Bostrom N, Kadidle DM, Fautsch S, McNearney S, Dewaard R, McGlave PB, Weisdorf DJ, Wagner JE.  Good Manufacturing Practices Production of Natural Killer Cells for Immunotherapy: A Six Year Single-Institution Experience.  Transfustion. 47: 520-8 (2007). 

Adamkiewicz TV, Haight A, Szabolcs P, Baker KS, Kedar A, Staba S, Chiang KY, Mazur MA, Krishnamurti L, Boyer MW, Kurtzberg J, Wagner JE, Wingard JR, Yeager AM.  Unrelated Cord Blood Transplantation in Children With Sickle Cell Disease: Review of Four Centers Experience.  Pediatric Transplantation.  11: 641-644 (2007). 

Flynn CM, Hirsch B, DeFor T, Barker JN, Miller JS, Wagner JE, Blazar BR, Burns LJ, MacMillan ML, Arora M, Weisdorf D.  Reduced Intensity Compared to High Dose Conditioning for Allotransplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Comparative Clinical Analysis.  Am J Hematology. (Epub ahead of Print) (2007) 

Markova M, Barker JN, Miller JS, Arora M, Wagner JE, Burns LJ, MacMillan ML, Douek D, DeFor T, Tan Y, Repka T, Blazar BR, Weisdorf DJ.  Fludarabine vs Cladribine Plus Busulfan and Low-Dose TBI as Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Randomized Trial.  Bone Marrow Transplant. 39: 193-9 (2007). 

Tomblyn M, Burns LJ, Blazar B, Wagner JE, Lee C, Rogers T, McGlave P, Miller JS, Weisdorf DJ.  Difficult Stem Cell Mobilization Despite Adequate CD34+ Cell Dose Predicts Shortened Progression Free and Oerall Survival After Autologous HSCT for Lymphoma.  Bone Marrow Transplantation.  40: 111-8 (2007).

Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Chaplin RE, Klein JP, Horowitz MM, Wagner JE.  Outcomes of Transplantation of Unrelated Donor Umbilical Cord Blood and Bone Marrow In Children with Acute Leukemia: A Comparison Study.  Lancet. 369:1947-54 (2007).

Porter SB, Liu B, Rogosheske J, Levine BL, June CH, Kohl VK, Wagner JE, Miller JS, Blazar BR.  Suppressor Function of Umbilical Cord Blood (UCB) Derived CD4+CD25+ T-Regulatory (Treg) Cells Exposed to Graft-Versus-Host Disease (GVHD) Drugs.  Transplantation.  Transplantation 82:23-9 (2006).

Martin PL, Carter, SL, Kernan NA, Sahdev I, Wall D, Pietryga D, Wagner JE, Kurtzverg J.  Results of the Cord Blood Transplantation Study (COLBT):  Transplant Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients With Lysosomal and Peroxisomal Storage Diseases.  Biol Blood Marrow Transplant.  12:184-94 (2006).

Eapen M, Rubinstein P, Zhang MJ, Camitta B, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE.  Comparable Long-Term Survival After Unrelated and HLA-Matched Sibling Hematopoietic Stem Cell Transplants for Acute Leukemia in Children Less Then 18 Months. J. Clin Oncology. 24:145-151 (2006).

Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA, Wagner JE.  Marked Increased Risk of Epstein-Barr Virus-Related Complications with the Additional of Anti-Thymocyte Globulin to a Non-Myeloablative Conditioning prior to Umbilical Cord Blood Transplantation.  Blood. 108: 2874-80 (2006). 

Schoemans H, Wagner JE, Maertens J, Theunissen K, Verfaillie C, Boogaerts M.  Adult Umbilical Cord Blood Transplantation:  A Comprehensive Review.  Bone Marrow Transplantation.  38:89-93 (2006). 

Majhail NS, Brunstein DC, Wagner JE.  Double Umbilical Cord Blood Transplantation. Current Opinions in Immunology.  18:571-575 (2006). 

Majhail NS, Weisdorf DJ, Wagner JE, DeFor TE, Brunstein CG, Burns LJ.   Comparable Results of Umbilical Cord Blood and HLA Matched Sibling Donor Hematopoietic Stem Cell Transplant After Reduced-Intensity Preparative Regimen For Advanced Hodgkin’s Lymphoma.  Blood.  107:3804-7 (2006). 

Brunsteim CG, Wagner JE.  Cord Blood Transplantation for Adults.  Vox Sanguinis 91:195-205 (2006). 

Parkman R, Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E, Kurtzberg J, Wagner JE, Kernan NA.  Successful Immune Reconstruction Decreases Leukemic Relapse and Improves Survival in Recipients of Unrelated Cord Blood Transplantation.  Biol Blood Marr Transplant.  12:919-927 (2006). 

Cohen G, Carter, SL, Weinberg KI, Masinsin B, Guinan E, Kurtzberg J, Wagner JE, Kernan NA, Parkman R.  Antigen-specific T-Lymphocyte Function After Cord Blood Transplantation.  Biol Blood Marrow Transplant. 12:1335-42 (2006).

Hurley CK, Wagner JE, Setterholm JI, Confer DL.  Advances in HLA: Practical Implications for Selecting Adult Donors and Cord Blood Units. 12:28-33 (2006). 

Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney S, Yun G, Fautsch SK, McKenna D, Le C, DeFor TE, Burns LJ, Orchard PJ, Blazar BR, Wagner JE, Slungaard A, Weisdorf DJ, Okazaki IJ, McGlave PB.  Successful Adoptive Transfer and In Vivo Expansion of Human Haploidentical NK Cells in Cancer Patients.  Blood. 105:3051-7 (2005). 

McKenna DH, Kadidlo DM, Miller JS, Orchard PJ, Wagner JE, McCullough J.  The Minnesota Molecular and Cellular Therapeutics Facility: a State-of-the-Art Biotherapeutics Engineering Laboratory.  Transfus Med Rev. 3:217-28 (2005). 

Cornetta K, Laughlin M, Carter S, Wall D, Weinthal J, Sievers E, Wagner JE, Sweetman R, McCarthy P, Jensen L, Nelson C.  Umbilical Cord Blood Transplantation in Adults:  Results of the Prospective Cord Blood Transplantation (COBLT).  Biol Blood Marrow Transplant.  11:149-60 (2005). 

Barker J, Hough RE, Van Burik J, DeFor T, MacMillan ML, O’Brien MR, Wagner JE.  Serious Infections After Unrelated Donor Transplantation in 136 Children:  Impact of Stem Cell Source.  Biol Blood Marrow Transplant.  11:362-70 (2005). 

Wagner JE, Thompson JS, Carter SL, Kernan NA.  Effect of Graft-Versus-Host Disease Prophylaxis on 3-Year Disease Free Survival in Recipients of Unrelated Donor Bone Marrow Transplantation:  Results of a Multi-Center, Randomized Phase II-III Trial.  Lancet.  366:733-41 (2005). 

Tan PL, Wagner JE, Auerbach AD, DeFor TE, MacMillan ML, Slungaard A.  Successful Engraftment Without Radiation After Fludarabine-Based Regimen in Fanconi anemia Patients Undergoing Genotypically Identical Donor Hematopoietic Cell Transplantation.  Pediatr Blood Cancer.  46:630-6 (2005). 

Wall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA, Frangoul H, Goyal RK, Horan JT, Pietryga D, Wagner JE, Kurtzberg J, On Behalf of COBLT Steering Committee.  Busulfan/Melphalan/ATG Followed by Unrelated Donor Cord Blood Transplantation for Treatment of Infant Leukemia and Leukemia in Young Children:  the COBLT Experience.  Biol Blood Marrow Transplant.  8:637-46 (2005). 

Fraser CJ, Hirsch BA, Dayton V, Creer MH, Neglia JP, Wagner JE, Baker KS. First Report of Donor Cell-Derived Acute Leukemia as a Complication of Umbilical Cord Blood Transplantation.  Blood.  106:4377-80 (2005). 

MacMillan ML, Wagner JE.  Hematopoietic Cell Transplantation for Congenital Bone Marrow Failure.  Curr Oin Oncol.  17:106-13 (2005). 

Wagner JE.  Practical and Ethical Issues with Genetic Screening.  American Society of Hematology.  498-502 (2005). 

Hough RE, Vora AJ, Wagner JE.  Innovative Strategies To Improve Outcome of Unrelated Donor Umbilical Cord Blood Transplantation. BloodMed. ISSN: 1478-1247 (2005). 

Kumar AR, Wagner JE, Auerbach AD, Coad JE, Dietz CA, Schwarzenberg SJ, MacMillan ML.  Fatal Intrahepatic Hemorrhage Due to Androgen-Related Hepatic Adenoma After Hematopoietic Cell Transplantation.  Pediatric Hematology/Oncology/Blood and Marrow Transplantation. N 26:16-18 (2004). 

Vallera DA, Elson M, Brechbiel MW, Dusenbery KE, Burns LJ, Jaszcz WB, Ramsay NK, Panoskaltsis-Mortari A, Kuroki DW, Wagner JE, Vitetta ES, Kersey JH.  Radiotherapy of CD19 Expressing Daudi Tumors in Nude Mice.  Cancer Biother Radiopharm.  19:11-23 (2004). 

Grewal SS, MacMillan ML, Kahn JP, Ramsay NKC, Wagner JE.  Successful Hematopoietic Stem Cell Transplantation for Fanconi Anemia from an Unaffected HLA Genotypically-Identical Sibling Selected Using Preimplantation Genetic Diagnosis.  Blood.  103:1147-1151 (2004). 

Wagner JE, Tolar J, Levran O, Schol T, Deffenbaugh A, Satagopan J, Ben-Porat L, Mah K, Batish S, Kutler D, MacMillan M, Hanenberg H, Auerbach A.  Germline Mutation in BRCa2:  Shared Genetic Susceptibility to Breast Cancer, Early Onset Leukemia and Fanconi Anemia.  Blood.  103:3226-9 (2004). 

Grewal S, Shapiro EG, Krivit W, Charnes L, Lockman LA, Delaney KA, Davies SM, Wenger DA, Rimell FL, Abel S, Grvas AC, Orchard PJ, Peters C, Wagner JE.  Effective Treatment of Alpha-Mannosidosis by Allogeneic Hematopoietic Stem Cell Transplantation.  J Pediatr.  144:569-73 (2004). 

Laughlin MJ, M Eapen, Rubenstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens CE, Barker JN, Gale RP, Lazarus HM, Marks DI, Van Rood JJ, Scaravadou A, Horowitz MM.  Outcomes After Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia.  New Engl J Med.  22:2265-75 (2004). 

Wagner JE, Verfaillie CM.  Ex Vivo Expansion of Umbilical Cord Blood Hemopoietic Stem and Progenitor Cells.  Exp Hematol.  32:412-413 (2004). 

Barker JN, Weisdorf DJ, DeFor TE, Blazar, McGlave PB, Miller JS, Verfaillie CM, Wagner JE.  Transplantation of Two-Partially HLA-Matched Umbilical Cord Blood Units to Enhance Engraftment in Adult with Hematologic Malignancy.  Blood.  105:1343-7 (2004). 

Eapen M, Horowitz MM, Klein JP, Champlin RE, Loveriza FR, Ringend O, Wagner JE.  Higher Mortality After Allogeneic Peripheral-Blood Transplantation Compared With Bone Marrow in Children and Adolescents:  The Histocompatibility and Alternative Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.  J Clin Oncol.  22:4872-80 (2004). 

Wagner JE, Kahn JP, Wolf SM, Lipton FM.  Preimplantation Testing to Produce an HLA Matched Donor Infant.  JAMA.  292:803-804 (2004). 

Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringden O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M.  Second Transplant for Acute and Chronic Leukemia Relapsing After First HLA-Identical Sibling Transplant.  Bone Marrow Transplant. 34:721-7 (2004). 

Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner JE, Weisdorf D.  A Comparison of Related Donor Peripheral Blood and Bone Marrow Transplants:  Importance of Late-Onset Chronic Graft-versus-Host Disease and Infections.  Biol Blood Marrow Transplant.  1:52-9 (2003). 

Vallera DA, Elson M, Brechbiel MW, Dusenbery KE, Burns LJ, Skubitz KM, Jaszcz WB, Ramsay NK, Panoskaltsis-Mortari A, Wagner JE, Kersey JH.  Preclinical Studies Targeting Normal and Leukemia Hematopoietic Cells with Yttrium-90-Labeled Anti-CD45 Antibody In Vitro in Nude Mice.  Ca Biother & Radiopharm.  18:133-145 (2003). 

Grewal SS, Barker JN, Davies SM, and Wagner JE.  Unrelated Donor Hematopoietic Cell Transplantation:  Marrow or Umbilical Cord Blood?  Blood.  101:4233-44 (2003). 

Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE.  Rapid and Complete Donor Chimerism in Adult Recipients of Unrelated Donor Umbilical Cord Blood Transplantation after Reduced Intensity Conditioning.  Blood.  102:1915-9 (2003). 

Weisdorf DJ, Hurd D, Carter S, Howe C, Jensen LA, Wagner JE, Stablein D, Thompson J, Kernan NA.  Prospective Grading of Graft-versus-Host Disease After Unrelated Donor Marrow Transplantation:  A Grading Algorithm Versus Blinded Expert Panel Review.  Biology Blood and Marrow Transplant.  9:512-8 (2003). 

Wolf SJ, Kahn JP, Wagner JE.  Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor:  Issues, Guidelines & Limits.  Journal of Law, Medicine and Ethics.  31:327-339 (2003). 

Liu BL, Buckley SM, Lewis ID, Goldman AI, Wagner JE, Van Der Loo JCM.  Homing Defect of Cultured Human Hematopoietic Cells in the NOD/SCID Mouse is Medicated by Fas/CD95.  Esp. Hematol.  31:824-832 (2003). 

Barker JN, Wagner JE.  Umbilical Cord Blood Transplantation for the Treatment of Cancer.  Nature Rev Cancer.  3:526-32 (2003). 

Barker JN, Wagner JE.  Umbilical Cord Blood Transplantation: Current Practice and Future Innovations.  Critical Reviews in Oncology Hematology. 48:35-43 (2003). 

Smith FO, King R, Nelson G, Wagner JE, Robertson KA, Sanders JE, Bunin N, Emaunel PD, Davies SM.  Unrelated Donor Bone Marrow Transplantation of Children with Juvenile Myelomonocytic Leukemia.  Bri J Haematol.  116:716-724 (2002). 

Warlick CA, Diers DD, Wagner JE, McIvor RS.  In Vivo Selection of Antifolate-Resistant Transgenic Hematopoietic Stem Cells in a Murine Bone Marrow Transplant Model.  J Pharmacol Therapeut.  300:50-56 (2002). 

Robertson JA, Kahn J, Wagner JE.  Conception to Obtain Hematopoiesis Stem Cells for Transplant.  Hastings Center Report, May-June:34-40, Commentary 11-12 (2002). 

Barker JN, Krepski T, Davies SM, DeFor T, Wagner JE, Weisdorf DJ.  Searching for Unrelated Donor Hematopoietic Stem Cells:  Availability and Speed of Umbilical Cord Blood Versus Bone Marrow.  Biol Blood Marrow Transplant.  8:257-260 (2002). 

MacMillan ML, Weisdorf DJ, Davies SM, DeFor TE, Burns LJ, Ramsay NKC, Wagner JE, Blazar BR.  Early Antithymocyte Globulin Therapy Improves Survival in Patients with Steroid-Resistant Acute Graft-Versus-Host Disease.  Biol Blood Marrow Transplant.  8:40-46 (2002). 

MacMillan M, Weisdorf D, Wagner JE, DeFor T, Burns L, Ramsay N, Davies S, Blazar B.  Response of 443 Patients to Steroids as Primary Therapy for Acute Graft-versus-Host Disease:  Comparison of Grading Systems.  Biol Blood Marrow Transplant.  8:387-394 (2002). 

Orchard PJ, Blazar BR, Burger S, Levine B, Basso L, Nelson DMK, Gordon K, McIvor RS, Wagner JE, Miller JS.  Clinical Scale Selection of Anti-CD3/CD28 Activated T Cells Following Transduction with a Retroviral Vector Expressing Herpes Simplex Virus Thymidine Kinase and Truncated Nerve Growth Factor Receptor.  Hum Gene Ther.  13:979-988 (2002). 

Wagner JE, Barker JN, DeFor T, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan M, Orchard P, Peters C, Weisdorf DJ, Ramsay NKC, Davies SM.  Transplantation of Unrelated Donor Umbilical Cord Blood in 102 Patients with Malignant and Non-Malignant Diseases:  Influence of CD34 Cell Dose and HLA Disparity on Treatment-Related Mortality and Survival.  Blood Advanced On Line Publication.  Blood.  100:1611-8 (2002). 

Davies SM, Ruggieri L, DeFor T, Wagner JE, Weisdorf DJ, Miller JS, Velardi A, Blazar BR.  An Evaluation of KIR Ligand Incompatibility in Mismatched Unrelated Donor Hematopoietic Transplant.  Blood.  100:3825-7 (2002). 

McKenna D, Rupp C, Wagner JE, McGlennen R, Hirsch B, Dolan M, Burger S, Hanson M, Jaszcz W, Nguyen P.  Increased Lymphoblast-like Cells Following Umbilical Cord Blood Stem Cell Transplantation do not Predict Recurrent Acute Leukemia.  Leukemia.  16:2171-2172 (2002). 

Krishnamurti L, Blazar BR, Orchard P, Lubin B, Avel S, Grossi M, Olson D, Vichinsky E, Wagner JE.  Bone Marrow Transplantation without Myeloablation for Sickle Cell Disease.  New Engl J Med.  [Letter-to-the-Editor] 344:68 (2001). 

Weinberg K, Blazar BR, Wagner JE, Collins RH, Agura E, Hill BJ, Smogorzewska M, Koup RA, Betts MR, Douek DC.  Factors Affecting Thymic Function After Allogeneic Hematopoietic Stem Cell Transplantation. Blood.  97:1458-1466 (2001). 

Barker JN, Davies SM, DeFor T, Ramsay NKC, Weisdorf DJ, Wagner JE.  Survival After Transplantation of Unrelated Donor Umbilical Cord Blood is Comparable to that of Human Leukocyte Antigen-Matched Unrelated Donor Bone Marrow:  Results of a Matched-Pair Analysis.  Blood.  97:2957-2961 (2001). 

Gregory JJ, Wagner JE, Verlander PC, Levran O, Batish SD, Eide CR, Steffenhagen A, Hirsch B, Auerbach AD.  Somatic Mosaicism in Fanconi Anemia:  Evidence of Genotypic Reversion in Lymphohematopoietic Stem Cells.  Proc Nat Acad Sci.  98:2532-2537 (2001). 

Davies SM, DeFor TE, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, Weisdorf DJ.  Equivalent Outcome in Patients with Chronic Myelogenous Leukemia after Early Transplantation of Phenotypically Matched Bone Marrow from Related or Unrelated Donors.  Am J Med.  110:339-349 (2001). 

Barker JN, Weisdorf DJ, Wagner JE.  Creation of a Double Chimera After the Transplantation of Umbilical-Cord Blood from Two Partially Matched Unrelated Donors.  N Engl J Med.  344:1870-1871 (2001). 

Laughlin MJ, Barder J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stefvvens CE, Rubinstein P, Kurtzberg J.  Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical Cord Blood Transplantation from Unrelated Donors.  N Engl J Med.  344:1815-1822 (2001). 

Arora M, Wagner JE, Davies SM, Blazar BR, DeFor T, Enright E, Miller W, Weisdorf D.  Randomized Clinical Trial of Thalidomide, Cyclosporine and Prednisone versus Cyclosporine and Prednisone as Initial Therapy of Chronic Graft vs. Host Disease.  Biol Blood Marrow Transplant.  7:265-273 (2001). 

Barker J, Martin P, Coad J, DeFor T, Trigg ME, Kurtzberg J, Weisdorf DJ, Wagner JE.  Low incidence of EBV-Associated Post-Transplant Lymphoproliferative Disorders (EBV-PTLD) in 272 Unrelated Donor Umbilical Cord Blood Transplant Recipients.  Biol Blood Marrow Transplant.  7:395-399 (2001). 

MacMillan ML, Auerbach AD, Davies SM, DeFor TE, Gillio A, Giller R, Harris R, Cairo M, Dusenbery D, Hirsch B, Ramsay NKC, Weisdorf DJ, Wagner JE.  Hematopoietic Cell Transplantation in Patients with Fanconi Anemia Using Alternate Donors:  Results of a Total Body Irradiation Dose Escalation Trial.  Br J Haematol.  109:121-9 (2000). 

Rocha V, Wagner JE, Sobcinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E. Graft versus Host Disease in Children Who Have Received a Cord Blood or Bone Marrow Transplant from an HLA Identical Sibling.  Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.  New Engl J Med.  342:1846-1854 (2000). 

deGasperi R, Raghavan SS, Sosa MG, Kolodny EH, Carrier C, Rubenstein P, Peters C, Wagner JE, Kurtzberg J, Krivit W.  Measurements from Normal Umbilical Cord Blood of Four Lysosomal Enzymatic Activities:  ?-L-Iduronidase (Hurler), Galactocerebrosidase (Globoid Cell Leukodystrophy), Arylsulfatase A (Metachromatic Leukodystrophy), Arylsulfatase B (Maroteaux-Lamy).  Bone Marrow Transplantation.  25:541-544 (2000). 

Krivit W, Peters C Dusenbery K, Ben-Yoseph Y, Ramsay NKC, Wagner JE, Anderson R.  Wolman Disease Successfully Treated by Bone Marrow Transplantation.  Bone Marrow Transplantation.  26:567-570 (2000). 

Marshall NA, Howe JG, Formica R, Krause D, Wagner JE, Berliner N, Crouch J, Pilip I, Cooper D, Blazar BR, Serpian S, Pamer EG.  Rapid Reconstitution of Epstein Barr Virus-Specific T Lymphocytes Following Allogeneic Stem Cell Transplantation.  Blood.  96:2814-2821 (2000). 

Lickliter JD, McGlave P, DeFor TE, Miller JS, Ramsay NK, Verfaillie CM, Burns LJ, Wagner JE, Eastlund T, Dusenbery K, Weisdorf DJ.  Matched-Pair Analysis of Peripheral Blood Stem Cells Compared to Marrow for Allogeneic Transplantation.  Bone Marrow Transplantation.  26:723-728 (2000). 

Browne PV, Weisdorf DJ, DeFor T, Miller WJ, Davies SM, Filipovich A, McGlave PB, Ramsay NKC, Wagner JE, Enright H.  Response to Thalidomide Therapy in Refractory Chronic Graft-Versus-Host Disease.  Bone Marrow Transplantation.  26:865-869 (2000).


Feedback | Notice of Privacy Practices